Three funded Postdoctoral positions available in the laboratory of Philipp Lange at UBC

Download more information at:

  • CIHR-funded position to lead work on the characterization and targeting of a new class of highly specific surface epitopes. More info and application.
  • PROFYLE-funded position to lead work on the development of mass spectrometry-based companion diagnostic assays for immunotherapies. More info and application.
  • Funded position to lead work on Histone-tail modification analysis. More info and application.

Research Associate position available in the laboratory of Philipp Lange (full-time or part-time)

Download the posting at:

Learn more about the research program in the Lange Lab:

“We seek an outstanding candidate with an exceptional passion to advance precision oncology for children and a fundamental understanding of proteome modulation in childhood disorders. In this role, you will oversee data analysis and reporting for multiple single-case and cohort studies in the precision oncology BRAvE and PROFYLE initiatives as well as collaboration projects. The workload for this position is scalable making this an excellent opportunity if you can not (or do not choose to) commit to full-time work (e.g. to care for dependents) but do not want to miss out on exciting, intellectually challenging and stimulating research.”

Find out more and apply today! 


  • PhD and PostDoc in cancer biology, immunology or related area and strong publication record (Exceptional recent PhD graduates may be considered for a post-doctoral position)
  • Fluent in written and spoken English and demonstrated excellence in scientific writing
  • Demonstrated exceptional analytical, communication and visualization skills.
  • Strong statistical foundation and expertise in R or python for data analysis
  • Exceptional understanding of biological mechanisms and well-read
  • Expertise mass spectrometry, genomics, cell surface and secretome characterization and precision medicine are assets but not required

CIHR Pre-announcement: Transforming Health with Integrated Care (THINC) – Implementation Science Teams Grants

The CIHR Institute of Health Services and Policy Research (IHSPR) in partnership with the CIHR Institute of Aging (IA), Institute of Circulatory and Respiratory Health (ICRH), Institute of Gender and Health (IGH), Institute of Genetics (IG), Institute of Human Development, Child and Youth Health (IHDCYH), Institute of Musculoskeletal Health and Arthritis (IMHA), the Strategy for Patient-Oriented Research (SPOR), New Brunswick Health Research Foundation (NBHRF), Ontario Ministry of Health (MOH), Saskatchewan Health Research Foundation (SHRF), and the Social Sciences and Humanities Research Council (SSHRC).

Anticipated Timelines*

Program Launch: June 2022
Webinar(s): 17 June 2022 at 2 – 3:30 pm EST (Join)
Full Application Deadline: 1 November 2022
Notice of Decisions:  March 2023
Funding Start Date: 1 April 2023
*These timelines are estimates and subject to change.

Relevant Research Areas

  • Health services and policy: Evidence-informed integrated care policies and interventions involving primary health care and advancing any/all of the Quadruple Aims and health equity.
  • Rural, Remote and Northern Communities: Integrated primary health care and other sectors within and/or beyond health care addressing the unique needs and contexts of rural, remote and/or northern communities.
  • Multi-Morbidity: Integrated care to improve care and experiences related to multimorbidity (where multimorbidity includes at least one of the six diseases/disorders relevant to the ICRH mandate and another chronic condition), with an emphasis on equity, diversity and inclusion, and/or Indigenous health and wellness.
  • Aging in the Right Place: Integration of health care, social services and policies to support older adults to remain and live independently in their residence of choice and then seamlessly transition to needed levels of care.
  • Transforming Health and Well-Being for Children and Youth: Integrated health, education, and/or social services and policies to create a healthier, stronger and more equitable future for children and youth in all their diversity.
  • Gender-Affirming Health: Integration of safe, inclusive, respectful and culturally competent gender affirming health care for lesbian, gay, bisexual, transgender, queer, questioning, intersex, asexual, and Two-Spirit (LGBTQIA/2S) communities across healthcare settings.
  • Integrated care models that improve outcomes of people who have diagnoses related to any elements of the broad IMHA mandate: the musculoskeletal system (including myalgic encephalomyelitis), arthritis, skin and dental conditions.
  • Genomics in Routine Care: Integrated care that transforms the diagnostic, treatment and management paradigm for rare/inherited disease patients by incorporating genetic testing s earlier in the care pathway and optimizing post-diagnostic treatment and support care pathways.
  • Interdisciplinary Approaches to Equitable, Diverse and Inclusive Integrated Care: Incorporating social science and humanities methodologies to improve our understanding of the living environment/conditions and socio-economic and psycho-social context of underrepresented or historically excluded groups and/or Indigenous Peoples, and how to implement equitable, diverse and inclusive integrated care systems/models of care that address their unique health needs and improves outcomes.

Precision Health Research Seminar | May 26 (11:30 am – 1pm MT) – free registration required

WCHRI, in collaboration with the Cancer Research Institute of Northern Alberta, Department of Pediatrics, Precision Health Signature Area (PHSA) and the Alberta Machine Intelligence Instituteare will host a precision health research seminar on May 26.

Norbert Graf, professor of Paediatrics and director of the Clinic for Paediatric Oncology and Haematology at Saarland University in Germany, will showcase research designed to bridge the gap between basic science and clinical oncology through the use of highly precise mathematical and visual models.

This virtual lecture will be moderated by Lesley Mitchell, Muriel and Ada Hole Kids with Cancer Society Chair in Paediatric Oncology.

Date: May 26
Time: 11:30 a.m. – 1 p.m. (Mountain)

Register at:

Contact N2 for ready to use materials for International Clinical Trials Day

What Are You Doing to Celebrate #ICTD2022?
N2 has a number of tools and resources that can be co-branded with N2 members. Please contact if you are interested in using any of these resources.
Downloadable: pamphlet, video, slides (clinical trials 101), postcard with It Starts With Me messaging
Ask Me campaign materials, including a training kit
International Clinical Trials Day information poster
Animated video, The Participators/ Les Super Participants – Enter the Study aimed to introduce children to clinical trials

Hybrid meeting: Decentralized Clinical Trials | 26 May 2022, 4:00 pm – 8:00 pm

$30.00 – $75.00

Hybrid: online + Seneca College Downtown 18 King St East, 17th Floor, Toronto, Ontario M5H 1A1 Canada

Register at:

Decentralized Clinical Trials are on the increase in Canada and around the world.  Join us on May 26th to hear about what is happening in Canada.

First Presentation:  A Canadian Model.

Stephen Sundquist,  Executive Director, Canadian Cancer Clinical Trials Network and Diana Kato, Manger Operations, Canadian Cancer Clinical Trials Network will speak about The Canadian Remote Access Framework for Clinical Trials (CRAFTwhich helps enable clinical trial participation for patients who live far from the healthcare site where the trial is primarily offered.

Second Presentation:  Lessons From Conducting 100% Virtual Trial

Dimitri Fitsialos, founder of Integrated Therapeutic Solutions will provide information on the 100% virtual study ongoing currently.  It has been an exciting trials with lots of lessons learned.

Third Presentation:  A Site Perspective

Seneca Harrison, ECO Quality Clinical Research will speak to decentralized trials and diversity.  They are currently involved in these trials which are enrolling indigenous participants.  He will discuss the challenges and rewards.

Other speaker to be announced SOON!

This will be a HYBRID meeting – small number in person and the rest will attend virtually.  For those attending in person, you must be vaccinated AND be masked for attendance.

Fertility Preservation: CPG Development and Implementation in the Netherlands (Drs. Wim Tissing and Marianne van de Wetering) | iPOG Webinar 20-Apr-2022 at 9am ET

Webinar Registration Link:

Twitter handle @IpogNetwork, link:

The international Pediatric Oncology Guidelines in supportive care (iPOG) Network is an inter-professional group with deep expertise in the supportive care of pediatric oncology patients, development of clinical practice guidelines and implementation of evidence-based care. We represent 9 local, national and international pediatric oncology organizations.

Learn more at

Webinar: Diagnostic considerations for optimizing successful outcomes in HLH | May 10 2022

Register at: and enter activity code HLH03224215

You are cordially invited to an accredited AMA/ANCC activity. Diagnostic Considerations for Optimizing Successful Outcomes in HLH

  • Educator: Michelle Hermiston, MD
  • Date: Tuesday, May 10, 2022
  • Time: 8:00 AM PT / 9:00 AM MT / 10:00 AM CT / 11:00 AM ET
  • Location: Live Webcast

Presented by: Clinical Viewpoints – A CME Lecture Series for hemophagocytic lymphohistiocytosis

This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications®. Supported by an independent educational grant from Sobi, Inc.

%d bloggers like this: